Obesity is a chronic condition that is characterized by inflammation and oxidative stress with consequent cardiovascular complications of hypertension, dyslipidemia, and vascular dysfunction. Obesity-induced metabolic syndrome remains an epidemic of global proportions.
Recent Advances:
Gene targeting of the endothelium with a retrovirus using an endothelium-specific promoter vascular endothelium cadherin (VECAD)-HO-1 offers a potential long-term solution to adiposity by targeting the endothelium. This has resulted in improvements of both vascular function and adiposity attenuation.
Critical Issues:
Heme oxygenase plays an ever-increasing role in the understanding of human biology in the complex conditions of obesity and the metabolic syndrome. The heme oxygenase 1 (HO-1) system creates biliverdin/bilirubin, which functions as an antioxidant, and carbon monoxide, which has antiapoptotic properties.
Future Directions:
Upregulation of HO-1 has been shown to improve adiposity as well as vascular function in both animal and human studies.
Get full access to this article
View all access options for this article.
References
1.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106: 3143–3421, 2002.
AbrahamNG, JungeJM, and DrummondGS. Translational significance of heme oxygenase in obesity and metabolic syndrome. Trends Pharmacol Sci, 37: 17–36, 2016.
4.
AbrahamNG, TsenovoyPL, McClungJ, and DrummondGS. Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des, 14: 412–421, 2008.
5.
Anjos-AfonsoF and BonnetD. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood, 109: 1298–1306, 2007.
6.
AtkinsGB, JainMK, and HamikA. Endothelial differentiation: molecular mechanisms of specification and heterogeneity. Arterioscler Thromb Vasc Biol, 31: 1476–1484, 2011.
7.
BallakDB, StienstraR, TackCJ, DinarelloCA, and van DiepenJA. IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance. Cytokine, 75: 280–290, 2015.
8.
BenskeyMJ and ManfredssonFP. Lentivirus production and purification. Methods Mol Biol, 1382: 107–114, 2016.
9.
BouzerdaA.Cardiovascular risk and obstructive sleep apnea [in French]. Pan Afr Med J, 29: 47, 2018.
10.
BurgessA, LiM, VanellaL, KimDH, RezzaniR, RodellaL, SodhiK, CanestraroM, MartasekP, PetersonSJ, KappasA, and AbrahamNG. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension, 56: 1124–1130, 2010.
11.
CaoH.Adipocytokines in obesity and metabolic disease. J Endocrinol, 220: T47–T59, 2014.
12.
CaoJ, PetersonSJ, SodhiK, VanellaL, BarbagalloI, RodellaLF, SchwartzmanML, AbrahamNG, and KappasA. Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet. Hypertension, 60: 467–475, 2012.
13.
CaoJ, SinghSP, McClungJ, JosephG, VanellaL, BarbagalloI, JiangH, FalckJR, AradM, ShapiroJI, and AbrahamNG. EET intervention on Wnt1, NOV and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice. Am J Physiol Heart Circ Physiol, 313: H368–H380, 2017.
14.
CaoJ, SodhiK, InoueK, QuilleyJ, RezzaniR, RodellaL, VanellaL, GerminarioL, StecDE, AbrahamNG, and KappasA. Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther, 22: 271–282, 2011.
15.
ChenL, AckermanR, SalehM, GotlingerKH, KesslerM, MendelowitzLG, FalckJR, ArbabAS, ScicliAG, SchwartzmanML, YangJ, and GuoAM. 20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo. J Pharmacol Exp Ther, 348: 442–451, 2014.
da SilvaSV, Renovato-MartinsM, Ribeiro-PereiraC, CitelliM, and Barja-FidalgoC. Obesity modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis. Obesity (Silver Spring), 24: 2522–2532, 2016.
19.
DozioE, VianelloE, MalavazosAE, TacchiniL, SchmitzG, IacobellisG, and Corsi RomanelliMM. Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk?. Int J Cardiol, 292: 218–224, 2019.
20.
DrummondHA, MitchellZL, AbrahamNG, and StecDE.Targeting heme oxygenase-1 in cardiovascular and kidney disease. Antioxidants (Basel), 8, 2019.
21.
FarbMG and GokceN. Visceral adiposopathy: a vascular perspective. Horm Mol Biol Clin Investig, 21: 125–136, 2015.
22.
FerrettiG, BacchettiT, MasciangeloS, and BicchiegaV. HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects. Obesity (Silver Spring), 18: 1079–1084, 2010.
23.
Florczyk-SoluchU, JozefczukE, StepniewskiJ, Bukowska-StrakovaK, MendelM, ViscardiM, NowakWN, JozkowiczA, and DulakJ. Various roles of heme oxygenase-1 in response of bone marrow macrophages to RANKL and in the early stage of osteoclastogenesis. Sci Rep, 8: 10797, 2018.
24.
GaoM and LiuD. Gene therapy for obesity: progress and prospects. Discov Med, 17: 319–328, 2014.
25.
GarciaV, ShkolnikB, MilhauL, FalckJR, and SchwartzmanML. 20-HETE activates the transcription of angiotensin-converting enzyme via nuclear factor-kappaB translocation and promoter binding. J Pharmacol Exp Ther, 356: 525–533, 2016.
26.
GeraertsM, EggermontK, Hernandez-AcostaP, Garcia-VerdugoJM, BaekelandtV, and DebyserZ. Lentiviral vectors mediate efficient and stable gene transfer in adult neural stem cells in vivo. Hum Gene Ther, 17: 635–650, 2006.
27.
GuoX, ChengL, YangS, and CheH.Pro-inflammatory immunological effects of adipose tissue and risk of food allergy in obesity: focus on immunological mechanisms. Allergol Immunopathol (Madr), 2019. [Epub ahead of print]; DOI: 10.1016/j.aller.2019.06.004.
28.
HaghighatN, MohammadshahiM, ShayanpourS, and HaghighizadehMH.Effect of synbiotic and probiotic supplementation on serum levels of endothelial cell adhesion molecules in hemodialysis patients: a randomized control study. Probiotics Antimicrob Proteins, 2018. [Epub ahead of print]; DOI: 10.1007/S12602-018-9509-5.
29.
Henriquez-OlguinC, BoronatS, Cabello-VerrugioC, JaimovichE, HidalgoE, and JensenTE. The emerging roles of NADPH oxidase 2 in skeletal muscle redox signaling and metabolism. Antioxid Redox Signal, 31: 1371–1410, 2019.
30.
HindsTDJr., SodhiK, MeadowsC, FedorovaL, PuriN, KimDH, PetersonSJ, ShapiroJ, AbrahamNG, and KappasA.Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity (Silver Spring), 22: 705–712, 2014.
31.
HoopesSL, GarciaV, EdinML, SchwartzmanML, and ZeldinDC. Vascular actions of 20-HETE. Prostaglandins Other Lipid Mediat, 120: 9–16, 2015.
32.
HuangPL.A comprehensive definition for metabolic syndrome. Dis Model Mech, 2: 231–237, 2009.
33.
IacobellisG, MohseniM, BiancoSD, and BangaPK. Liraglutide causes large and rapid epicardial fat reduction. Obesity (Silver Spring), 25: 311–316, 2017.
34.
JelicS and Le JemtelTH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med, 18: 253–260, 2008.
35.
Kalantar-ZadehK, KoppleJD, KamranpourN, FogelmanAM, and NavabM. HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int, 72: 1149–1156, 2007.
36.
KelsenS, PatelBJ, ParkerLB, VeraT, RimoldiJM, GadepalliRS, DrummondHA, and StecDE. Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells. Am J Physiol Renal Physiol, 295: F1158–F1165, 2008.
37.
KimCS, ChoiHS, JoeY, ChungHT, and YuR. Induction of heme oxygenase-1 with dietary quercetin reduces obesity-induced hepatic inflammation through macrophage phenotype switching. Nutr Res Pract, 10: 623–628, 2016.
38.
KinderlererAR, Pombo GregoireI, HamdulaySS, AliF, SteinbergR, SilvaG, AliN, WangB, HaskardDO, SoaresMP, and MasonJC. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Blood, 113: 1598–1607, 2009.
39.
KozakowskaM, Pietraszek-GremplewiczK, CieslaM, SeczynskaM, Bronisz-BudzynskaI, PodkalickaP, Bukowska-StrakovaK, LobodaA, JozkowiczA, and DulakJ. Lack of heme oxygenase-1 induces inflammatory reaction and proliferation of muscle satellite cells after cardiotoxin-induced skeletal muscle injury. Am J Pathol, 188: 491–506, 2018.
40.
KrugerAL, PetersonS, TurksevenS, KaminskiPM, ZhangFF, QuanS, WolinMS, and AbrahamNG. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation, 111: 3126–3134, 2005.
41.
KrugerAL, PetersonSJ, SchwartzmanML, FuscoH, McClungJA, WeissM, ShenoudaS, GoodmanAI, GoligorskyMS, KappasA, and AbrahamNG. Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther, 319: 1144–1152, 2006.
42.
LanY, LiuH, LiuJ, ZhaoH, and WangH. Is serum total bilirubin a predictor of prognosis in arteriosclerotic cardiovascular disease?. A meta-analysis. Medicine (Baltimore), 98: e17544, 2019.
43.
LiJY, WangYD, QiXY, RanL, HongT, YangJ, YanB, LiaoZZ, LiuJH, and XiaoXH. Serum CCN3 levels are increased in type 2 diabetes mellitus and associated with obesity, insulin resistance and inflammation. Clin Chim Acta, 494: 52–57, 2019.
44.
LiM, KimDH, TsenovoyPL, PetersonSJ, RezzaniR, RodellaLF, AronowWS, IkeharaS, and AbrahamNG. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes, 57: 1526–1535, 2008.
45.
LiM, PetersonS, HusneyD, InabaM, GuoK, KappasA, IkeharaS, and AbrahamNG. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle, 6: 567–571, 2007.
46.
LuH, CassisLA, KooiCW, and DaughertyA. Structure and functions of angiotensinogen. Hypertens Res, 39: 492–500, 2016.
47.
LuH, WuC, HowattDA, BalakrishnanA, MoorleghenJJ, ChenX, ZhaoM, GrahamMJ, MullickAE, CrookeRM, FeldmanDL, CassisLA, Vander KooiCW, and DaughertyA. Angiotensinogen exerts effects independent of angiotensin II. Arterioscler Thromb Vasc Biol, 36: 256–265, 2016.
48.
MaY, GaoM, and LiuD. Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer. Sci Rep, 6: 26242, 2016.
49.
MarceloKL, GoldieLC, and HirschiKK. Regulation of endothelial cell differentiation and specification. Circ Res, 112: 1272–1287, 2013.
50.
MartinerieC, GarciaM, DoTT, AntoineB, MoldesM, DorotheeG, KazazianC, AuclairM, BuyseM, LedentT, MarchalPO, FesatidouM, BeisseicheA, KosekiH, HiraokaS, ChadjichristosCE, BlondeauB, DenisRG, LuquetS, and FeveB. NOV/CCN3: a new adipocytokine involved in obesity-associated insulin resistance. Diabetes, 65: 2502–2515, 2016.
51.
MatsudaM and ShimomuraI. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract, 7: e330–e341, 2013.
52.
McAninchEA, FonsecaTL, PoggioliR, PanosAL, SalernoTA, DengY, LiY, BiancoAC, and IacobellisG. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity (Silver Spring), 23: 1267–1278, 2015.
53.
MonuSR, PesceP, SodhiK, BoldrinM, PuriN, FedorovaL, SacerdotiD, PetersonSJ, AbrahamNG, and KappasA. HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation. Hypertension, 62: 310–316, 2013.
54.
MoraesJA, Barcellos-de-SouzaP, RodriguesG, Nascimento-SilvaV, SilvaSV, AssreuyJ, ArrudaMA, and Barja-FidalgoC. Heme modulates smooth muscle cell proliferation and migration via NADPH oxidase: a counter-regulatory role for heme oxygenase system. Atherosclerosis, 224: 394–400, 2012.
55.
MorgantiniC, MeriwetherD, BaldiS, VenturiE, PinnolaS, WagnerAC, FogelmanAM, FerranniniE, NataliA, and ReddyST. HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. Nutr Metab Cardiovasc Dis, 24: 594–599, 2014.
56.
MorgantiniC, NataliA, BoldriniB, ImaizumiS, NavabM, FogelmanAM, FerranniniE, and ReddyST. Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes. Diabetes, 60: 2617–2623, 2011.
57.
MotamedM, NargesiAA, HeidariB, MirmiranpourH, EsteghamatiA, and NakhjavaniM. Oxidized low-density lipoprotein (ox-LDL) to LDL ratio (ox-LDL/LDL) and ox-LDL to high-density lipoprotein ratio (ox-LDL/HDL). Clins Lab, 62: 1609–1617, 2016.
58.
NaldiniL.Gene therapy returns to centre stage. Nature, 526: 351–360, 2015.
59.
NavabM, ReddyST, Van LentenBJ, AnantharamaiahGM, and FogelmanAM. The role of dysfunctional HDL in atherosclerosis. J Lipid Res, 50(Suppl): S145–S149, 2009.
60.
NavabM, ReddyST, Van LentenBJ, BugaGM, HoughG, WagnerAC, and FogelmanAM. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature. Arterioscler Thromb Vasc Biol, 32: 2553–2560, 2012.
61.
NdisangJF and JadhavA. Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology, 150: 2627–2636, 2009.
62.
OgdenCL, CarrollMD, KitBK, and FlegalKM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA, 311: 806–814, 2014.
63.
OlszaneckiR, RezzaniR, OmuraS, StecDE, RodellaL, BotrosFT, GoodmanAI, DrummondG, and AbrahamNG. Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway. Am. J Physiol Renal Physiol, 292: F148–F157, 2007.
64.
PaeHO, SonY, KimN-H, JeongHJ, ChangKC, and ChungH-T. Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide, 23: 251–257, 2010.
65.
PetersonSJ, DrummondG, KimDH, LiM, KrugerAL, IkeharaS, and AbrahamNG. L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res, 49: 1658–1669, 2008.
66.
PetersonSJ, HusneyD, KrugerAL, OlszaneckiR, RicciF, RodellaLF, StacchiottiA, RezzaniR, McClungJA, AronowWS, IkeharaS, and AbrahamNG. Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther, 322: 514–520, 2007.
67.
PetersonSJ, KimDH, LiM, PositanoV, VanellaL, RodellaLF, PiccolominiF, PuriN, GastaldelliA, KusmicC, L'AbbateA, and AbrahamNG. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res, 50: 1293–1304, 2009.
68.
PetersonSJ, RubinsteinR, FaroquiM, RazaA, BoumazaI, ZhangY, StecD, and AbrahamNG.Positive effects of heme oxygenase upregulation on adiposity and vascular dysfunction: gene targeting vs. pharmacologic therapy. Int J Mol Sci, 20, 2019.
69.
PetersonSJ, ShapiroJI, ThompsonE, SinghS, LiuL, WeingartenJA, O'HanlonK, BialczakA, BhesaniaSR, and AbrahamNG. Oxidized HDL, adipokines, and endothelial dysfunction: a potential biomarker profile for cardiovascular risk in women with obesity. Obesity (Silver Spring), 27: 87–93, 2019.
70.
PetersonSJ, VanellaL, BialczakA, SchragenheimJ, LiM, BellnerL, ShapiroJI, and AbrahamNG. Oxidized HDL and isoprostane exert a potent adipogenic effect on stem cells: where in the lineage?. Cell Stem Cells Regen Med, 2: 2472–6990, 2016.
71.
PetersonSJ, VanellaL, GotlingerK, JiangH, BialczakA, SinghSP, SodhiK, MaherE, O'HanlonK, ShapiroJI, and AbrahamNG. Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females. Prostaglandins Other Lipid Mediat, 123: 68–77, 2016.
72.
ReutterF, JungG, BaierW, TreyerB, BesslerWG, and WiesmullerKH. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections. J Pept Res, 65: 375–383, 2005.
73.
RochetteL, ZellerM, CottinY, and VergelyC. Redox functions of heme oxygenase-1 and biliverdin reductase in diabetes. Trends Endocrinol Metab, 29: 74–85, 2018.
74.
RuanX, LiZ, ZhangY, YangL, PanY, WangZ, FengGS, and ChenY. Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and upregulation of UCP1 in brown fat. J Cell Mol Med, 15: 763–772, 2010.
75.
RyterSW and ChoiAM. Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy. Am J Respir Cell Mol Biol, 41: 251–260, 2009.
76.
RyterSW and ChoiAM. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res, 167: 7–34, 2016.
77.
SchaferFQ and BuettnerGR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 30: 1191–1212, 2001.
78.
SchragenheimJ, BellnerL, CaoJ, SinghSP, BamshadD, McClungJA, MaayanO, MeissnerA, GrantI, StierCTJr., and AbrahamNG. EET enhances renal function in obese mice resulting in restoration of HO-1-Mfn1/2 signaling, and decrease in hypertension through inhibition of sodium chloride co-transporter. Prostaglandins Other Lipid Mediat, 137: 30–39, 2018.
79.
ShahD, TorresC, and BhandariV. Adiponectin deficiency induces mitochondrial dysfunction and promotes endothelial activation and pulmonary vascular injury. FASEB J, 33: 13617–13631, 2019.
ShermanCB, PetersonSJ, and FrishmanWH. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev, 18: 141–147, 2010.
82.
SinghS, GrantI, MeissnerA, KappasA, and AbrahamN.Ablation of adipose-HO-1 expression increases white fat over beige fat through inhibition of mitochondrial fusion and of PGC1alpha in female mice. Horm Mol Biol Clin Investig, 31, 2017.
83.
SinghS, McClungJ, ThompsonE, GlickY, GreenbergM, Acosta-BaezG, EdrisB, ShapiroJ, and AbrahamNG. Cardioprotective heme oxygenase-1-PGC-1α signaling in epicardial fat attenuates cardiovascular risk in humans as in obese mice. Obesity (Silver Spring), 27: 1634–1643, 2019.
84.
SinghSP, BellnerL, VanellaL, CaoJ, FalckJR, KappasA, and AbrahamNG. Downregulation of PGC-1alpha prevents the beneficial effect of EET-heme oxygenase-1 on mitochondrial integrity and associated metabolic function in obese mice. J Nutr Metab, 2016: Article ID 9039754, 2016.
85.
SinhaN and DablaPK. Oxidative stress and antioxidants in hypertension-a current review. Curr Hypertens Rev, 11: 132–142, 2015.
86.
StecDE, JuncosLA, and GrangerJP. Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II-dependent hypertension. J Am Soc Hypertens, 10: 346–351, 2016.
ThomasJJ and RenJ. Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge. Clin Exp Pharmacol Physiol, 39: 995–1003, 2012.
89.
TiwariS and NdisangJF. Heme oxygenase system and hypertension: a comprehensive insight. Curr Pharm Des, 20: 1354–1369, 2014.
90.
Trak-SmayraV, ParadisV, MassartJ, NasserS, JebaraV, and FromentyB. Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet. Int J Exp Pathol, 92: 413–421, 2011.
91.
TuTH, JoeY, ChoiHS, ChungHT, and YuR. Induction of heme oxygenase-1 with hemin reduces obesity-induced adipose tissue inflammation via adipose macrophage phenotype switching. Mediators Inflamm, 2014: 290708, 2014.
92.
VanellaL, CanestraroM, LeeCR, CaoJ, ZeldinDC, SchwartzmanML, and AbrahamNG. Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis. Prostaglandins Other Lipid Mediat, 120: 139–147, 2015.
93.
VanellaL, LiM, KimD, MalfaG, BellnerL, KawakamiT, and AbrahamNG. ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b. Cell Cycle, 11: 706–714, 2012.
94.
VanellaL, SodhiK, KimDH, PuriN, MaheshwariM, HindsTD, BellnerL, GoldsteinD, PetersonSJ, ShapiroJI, and AbrahamNG. Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade. Stem Cell Res Ther, 4: 28, 2013.
95.
VeraT, HenegarJR, DrummondHA, RimoldiJM, and StecDE. Protective effect of carbon monoxide-releasing compounds in ischemia-induced acute renal failure. J Am Soc Nephrol, 16: 950–958, 2005.
96.
WaldmanM, BellnerL, VanellaL, SchragenheimJ, SodhiK, SinghSP, LinD, LakhkarA, LiJ, HochhauserE, AradM, DarzynkiewiczZ, KappasA, and AbrahamNG. Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3 cells, via PGC-1alpha activation, which is required for HO-1 expression and increased mitochondrial function. Stem Cells Dev, 25: 1084–1094, 2016.
97.
WazaAA, HamidZ, AliS, BhatSA, and BhatMA. A review on heme oxygenase-1 induction: is it a necessary evil. Inflamm Res, 67: 579–588, 2018.
98.
WeingartenJ, BellnerL, PetersonS, ZawM, ChadhaP, SinghS, and AbrahamN.The association of NOV/CCN3 with obstructive sleep apnea (OSA): preliminary evidence of a novel biomarker in OSA. Horm Mol Biol Clin Investig, 31, 2017.
99.
WessL and SchniedersF. Immuno-oncology-the translational runway for gene therapy: gene therapeutics to address multiple immune targets. Hum Gene Ther, 28: 1130–1137, 2017.
100.
WuML, HoYC, and YetSF. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal, 15: 1835–1846, 2011.
101.
YoungSC, StormMV, SpeedJS, KelsenS, TillerCV, VeraT, DrummondHA, and StecDE. Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells. Am J Physiol Regul Integr Comp Physiol, 297: R1546–R1553, 2009.
102.
YunokiK, NarukoT, InabaM, InoueT, NakagawaM, SugiokaK, OhsawaM, IwasaY, KomatsuR, ItohA, HazeK, YoshiyamaM, BeckerAE, and UedaM. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease. Atherosclerosis, 231: 308–314, 2013.
